Tourmaline Bio Stock (NASDAQ: TRML) stock price, news, charts, stock research, profile.
You can purchase shares of Tourmaline Bio (NASDAQ:TRML) through any online brokerage.
Other companies in Tourmaline Bio’s space includes: Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT), Sangamo Therapeutics (NASDAQ:SGMO) and Opthea (NASDAQ:OPT).
Tourmaline Bio has a consensus price target of $55.83.
The stock price for Tourmaline Bio (NASDAQ: TRML) is $20.78 last updated December 24, 2024 at 1:51 PM EST.
There are no upcoming dividends for Tourmaline Bio.
Tourmaline Bio’s Q4 earnings are confirmed for Tuesday, March 18, 2025.
There is no upcoming split for Tourmaline Bio.
Tourmaline Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.